Content |
History
2016: Creation of L1 Health company and plans of LetterOne for investment of $3 billion
On June 6, 2016 the LetterOne holding announced plans to invest up to $3 billion in health care. For these purposes the new company which received the name L1 Health was created.
As it appears from the message of LetterOne, the task of purchase of "considerable shares" in the capital of the perspective medical companies is set for L1 Health to help them with development. In total in the market of health care it is going to invest $2-3 billion within three years.
LetterOne explained entry into the market, new to itself with the growing demand for consumption of services of health care in the world. According to data which were provided by the company in the press release, world expenses on health care will grow from 2014 to 2018 by 5.2%, and the share of costs for health care in the USA in 2018 will reach 18% of GDP.
The health sector quickly develops that creates unique investment opportunities for L1 Health — Mikhail Friedman who is one of co-owners of LetterOne noted. |
Rapid growth of demand for medical services from the middle class which total number in the next years will increase approximately by a third should become one more incentive of development. Experts of LetterOne believe that by the end of 2018 in the world there will be about 570 million people with an annual income more than $25 thousand.
The holding also reported that Franz Humer, from 2008 to 2014 the heading Board of Directors of Roche Holding is appointed the first participant of the L1 Health advisory board. At the time of new appointment Humer directed Board of Directors of the British Diageo, one of the world's largest of the producer of alcoholic beverages (Johnnie Walker, White Horse, Baileys, Gordon's and other brands).
Building of global investment business will be the main objective of the new top manager, according to Friedman.[1]